ArticleNeuro-oncology2017

Cost-effectiveness of IDH testing in diffuse gliomas according to the 2016 WHO classification of tumors of the central nervous system recommendations.

John C DeWitt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.